Navigation Links
High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers
Date:3/5/2009

DALLAS, March 5 /PRNewswire-USNewswire/ -- Yesterday's Supreme Court ruling against preemption is disastrous for patient access to necessary medicines and research for new therapies, and clearly elevates trial lawyers and local juries as the de facto authority on drug safety.

The high court has decided that federal law does not preempt state law in matters of drug safety, and consequently, a flood of frivolous liability lawsuits will cause patients to lose access to critical new medicines.

"The victors in this decision claim that eliminating preemption would make drug companies more rigorous in ensuring their drugs are safe; unfortunately, it would more likely make companies invention-averse," said Institute for Policy Innovation (IPI) resident scholar and health care expert Dr. Merrill Matthews.

Without preemption, drug makers will be more risk averse, as they grind themselves for legal battles. The result is that patients will lose access to necessary medicines and research into new cures will decline.

"This is a win-win situation for trial lawyers, and a lose-lose for patients," said Matthews. "Lawsuits are expensive, and even the threat of baseless litigation can cause pharmaceutical firms to slow down and even stop creating and developing new products.

"Plaintiff Diana Levine's story is tragic, and the physician's assistant who misused the clearly labeled drug should be, and was, held accountable. But it's hard to see how the maker of the drug could be at fault," said Matthews.

Without a strong preemption principle, average Americans who serve on local juries will be asked to overrule the government scientists and medical experts who oversee the drug-approval process.

"Trial lawyers know that jurors are ill-suited to evaluate the merits of drug warning labels, which is exactly why they're behind this effort. Without preemption we'll see a surge of frivolous lawsuits against pharmaceutical companies and other manufacturers." said Matthews.

The Institute for Policy Innovation is an independent, non-profit public policy organization based in Dallas, Texas. Dr. Merrill Matthews is available for interview by contacting Erin Humiston at (972) 874-5139, or erin@ipi.org.


'/>"/>
SOURCE Institute for Policy Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
3. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
4. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
5. Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
6. Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research
7. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
8. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
9. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
10. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights
11. ALLs Judie Brown: Supreme Court is Wrong on Contraception Ruling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... 08, 2016 , ... Tingley Rubber Corporation , a ... its range of unique and advantaged protective solutions to a growing and ... bilingual customer service and marketing support. A new distribution center in Brampton, Ontario ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... , ... February 08, 2016 , ... TopConsumerReviews.com recently awarded ... Mole removal products. , Moles are derived from a cluster of melanin when exposed ... the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
Breaking Medicine Technology: